Report: Cigarette Smoking Rate Drops to Record Low 9.9%

Why It Matters

The drop signals progress for public‑health goals and reduces future healthcare costs, while the steady share of non‑combustible product use forces the tobacco industry to re‑orient its product strategies and regulators to broaden oversight.

Key Takeaways

• Smoking prevalence fell to 9.9% in 2024.
• Record low reflects decades‑long decline in cigarette use.
• Overall tobacco use remains at 18.8% of adults.
• E‑cigarette and cigar consumption stayed steady.
• 47.7 million adults still use at least one tobacco product.

Pulse Analysis

The latest National Health Interview Survey analysis confirms that U.S. adult cigarette smoking has slipped to 9.9% in 2024, a historic low. This milestone builds on a sustained downward trajectory driven by higher excise taxes, expanded smoke‑free laws, and aggressive public‑health campaigns such as the CDC’s Tips From Former Smokers. State‑level initiatives, including Medicaid coverage for cessation therapies, have widened access to nicotine‑replacement products, accelerating quit rates among middle‑aged and older smokers. The decline also reflects generational shifts, as younger adults increasingly view smoking as socially unacceptable.

While combustible cigarette use contracts, the broader tobacco landscape remains sizable. The report shows that 18.8% of adults—roughly 47.7 million people—still consume at least one tobacco product, with e‑cigarette and cigar usage holding steady. This stability signals a market pivot toward alternative nicotine delivery systems, prompting major tobacco firms to double down on vaping and heated‑tobacco portfolios. Investors are watching product‑mix transformations closely, as regulatory scrutiny intensifies around flavor bans and youth‑access restrictions. The unchanged prevalence of non‑combustible products suggests that cessation efforts must now address a more diversified nicotine ecosystem.

Public‑health officials caution that the remaining tobacco burden is unevenly distributed, with higher smoking rates persisting in low‑income and rural communities. Targeted interventions—such as mobile quit‑line services and community‑based outreach—will be critical to bridge these gaps. Moreover, surveillance must expand beyond cigarettes to capture emerging trends in nicotine pouches and synthetic nicotine products. As the industry adapts, policymakers face a dual challenge: sustaining the momentum that drove cigarette rates down while preventing a substitution effect that could erode health gains. Continued data collection will be essential for evidence‑based regulation.